Case Presentations & Best Practices for Medication Assisted Treatment (MAT)
Presented by: Aaron Newcomb, DO, Family & Addiction Medicine, Shawnee Health Services, Carbondale, IL

Click here to register

Learning Objectives:

• Understand behavioral health can be a very effective part of treatment during MAT but it is not intended to be a mandate for buprenorphine access.
• Recall that Buprenorphine treatment length is best measured in years rather than months.
• Understand that Universal Prescribing of daily doses at 16mg or less is substandard care not diversion mitigation.
• Explain that Toxicology testing can be used to help strengthen the therapeutic relationship when used to guide rather than discontinue buprenorphine treatment.
• Discuss that patients with imperfect results who have continued drug use during buprenorphine treatment should not have their medication discontinued just as a diabetic patient with imperfect glycemic control should not have their insulin stopped.